ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Epigenetic Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-33G16889
Home | Market Reports | Science| Biological Sciences
Global Epigenetic Kits Market Research Report 2024
BUY CHAPTERS

Global Epigenetic Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33G16889
Report
November 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qiagen NV
Diagenode
Active Motif
Cayman Chemical
Aviva Biosciences
Zymo Research

Epigenetic Kits Market

The global Epigenetic Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Oncology accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Epigenetic Kits leading manufacturers including Illumina, Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Qiagen, Diagenode, Active Motif, Cayman Chemical, Aviva Biosciences, Zymo Research, etc., dominate supply; the top five capture approximately % of global revenue, with Illumina leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Epigenetic Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Epigenetic Kits Market Report

Report Metric Details
Report Name Epigenetic Kits Market
Segment by Type
  • Nucleic Acid Methylation Assay Kit
  • Chromatin Modification Detection Kit
  • Histone Methylation Assay Kit
  • Other
Segment by Application
  • Oncology
  • Developmental Biology
  • Drug Discovery
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Qiagen, Diagenode, Active Motif, Cayman Chemical, Aviva Biosciences, Zymo Research
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Epigenetic Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Epigenetic Kits Market report?

Ans: The main players in the Epigenetic Kits Market are Illumina, Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Qiagen, Diagenode, Active Motif, Cayman Chemical, Aviva Biosciences, Zymo Research

What are the Application segmentation covered in the Epigenetic Kits Market report?

Ans: The Applications covered in the Epigenetic Kits Market report are Oncology, Developmental Biology, Drug Discovery, Others

What are the Type segmentation covered in the Epigenetic Kits Market report?

Ans: The Types covered in the Epigenetic Kits Market report are Nucleic Acid Methylation Assay Kit, Chromatin Modification Detection Kit, Histone Methylation Assay Kit, Other

1 Study Coverage
1.1 Introduction to Epigenetic Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Epigenetic Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nucleic Acid Methylation Assay Kit
1.2.3 Chromatin Modification Detection Kit
1.2.4 Histone Methylation Assay Kit
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Epigenetic Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Developmental Biology
1.3.4 Drug Discovery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Epigenetic Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Epigenetic Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Epigenetic Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Epigenetic Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Epigenetic Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Epigenetic Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Nucleic Acid Methylation Assay Kit Market Size by Manufacturers
3.5.2 Chromatin Modification Detection Kit Market Size by Manufacturers
3.5.3 Histone Methylation Assay Kit Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Epigenetic Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Epigenetic Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Epigenetic Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Epigenetic Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Epigenetic Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Epigenetic Kits Sales and Revenue by Type (2020-2031)
6.4 North America Epigenetic Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Epigenetic Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Epigenetic Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Epigenetic Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Epigenetic Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Epigenetic Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Epigenetic Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Epigenetic Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Epigenetic Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Epigenetic Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Epigenetic Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Epigenetic Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Epigenetic Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Epigenetic Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina Epigenetic Kits Product Models, Descriptions and Specifications
11.1.4 Illumina Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Illumina Epigenetic Kits Sales by Product in 2024
11.1.6 Illumina Epigenetic Kits Sales by Application in 2024
11.1.7 Illumina Epigenetic Kits Sales by Geographic Area in 2024
11.1.8 Illumina Epigenetic Kits SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Epigenetic Kits Product Models, Descriptions and Specifications
11.2.4 Thermo Fisher Scientific Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific Epigenetic Kits Sales by Product in 2024
11.2.6 Thermo Fisher Scientific Epigenetic Kits Sales by Application in 2024
11.2.7 Thermo Fisher Scientific Epigenetic Kits Sales by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific Epigenetic Kits SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Corporation Information
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Epigenetic Kits Product Models, Descriptions and Specifications
11.3.4 Agilent Technologies Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Agilent Technologies Epigenetic Kits Sales by Product in 2024
11.3.6 Agilent Technologies Epigenetic Kits Sales by Application in 2024
11.3.7 Agilent Technologies Epigenetic Kits Sales by Geographic Area in 2024
11.3.8 Agilent Technologies Epigenetic Kits SWOT Analysis
11.3.9 Agilent Technologies Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Corporation Information
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Epigenetic Kits Product Models, Descriptions and Specifications
11.4.4 Merck KGaA Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Merck KGaA Epigenetic Kits Sales by Product in 2024
11.4.6 Merck KGaA Epigenetic Kits Sales by Application in 2024
11.4.7 Merck KGaA Epigenetic Kits Sales by Geographic Area in 2024
11.4.8 Merck KGaA Epigenetic Kits SWOT Analysis
11.4.9 Merck KGaA Recent Developments
11.5 Qiagen
11.5.1 Qiagen Corporation Information
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Epigenetic Kits Product Models, Descriptions and Specifications
11.5.4 Qiagen Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Qiagen Epigenetic Kits Sales by Product in 2024
11.5.6 Qiagen Epigenetic Kits Sales by Application in 2024
11.5.7 Qiagen Epigenetic Kits Sales by Geographic Area in 2024
11.5.8 Qiagen Epigenetic Kits SWOT Analysis
11.5.9 Qiagen Recent Developments
11.6 Diagenode
11.6.1 Diagenode Corporation Information
11.6.2 Diagenode Business Overview
11.6.3 Diagenode Epigenetic Kits Product Models, Descriptions and Specifications
11.6.4 Diagenode Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Diagenode Recent Developments
11.7 Active Motif
11.7.1 Active Motif Corporation Information
11.7.2 Active Motif Business Overview
11.7.3 Active Motif Epigenetic Kits Product Models, Descriptions and Specifications
11.7.4 Active Motif Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Active Motif Recent Developments
11.8 Cayman Chemical
11.8.1 Cayman Chemical Corporation Information
11.8.2 Cayman Chemical Business Overview
11.8.3 Cayman Chemical Epigenetic Kits Product Models, Descriptions and Specifications
11.8.4 Cayman Chemical Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Cayman Chemical Recent Developments
11.9 Aviva Biosciences
11.9.1 Aviva Biosciences Corporation Information
11.9.2 Aviva Biosciences Business Overview
11.9.3 Aviva Biosciences Epigenetic Kits Product Models, Descriptions and Specifications
11.9.4 Aviva Biosciences Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Aviva Biosciences Recent Developments
11.10 Zymo Research
11.10.1 Zymo Research Corporation Information
11.10.2 Zymo Research Business Overview
11.10.3 Zymo Research Epigenetic Kits Product Models, Descriptions and Specifications
11.10.4 Zymo Research Epigenetic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Zymo Research Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Epigenetic Kits Industry Chain
12.2 Epigenetic Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Epigenetic Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Epigenetic Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Epigenetic Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Epigenetic Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Qiagen NV
Diagenode
Active Motif
Cayman Chemical
Aviva Biosciences
Zymo Research
List of Tables
 Table 1. Global Epigenetic Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Epigenetic Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Epigenetic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Epigenetic Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Epigenetic Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Epigenetic Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Epigenetic Kits Sales by Region (2020-2025) & (K Units)
 Table 8. Global Epigenetic Kits Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Epigenetic Kits Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Epigenetic Kits Sales Share by Manufacturers (2020-2025)
 Table 12. Global Epigenetic Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Epigenetic Kits Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Epigenetic Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetic Kits as of 2024)
 Table 16. Global Epigenetic Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Epigenetic Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Epigenetic Kits Manufacturing Base and Headquarters
 Table 19. Global Epigenetic Kits Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Epigenetic Kits Sales by Type (2020-2025) & (K Units)
 Table 23. Global Epigenetic Kits Sales by Type (2026-2031) & (K Units)
 Table 24. Global Epigenetic Kits Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Epigenetic Kits Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Epigenetic Kits ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Epigenetic Kits Sales by Application (2020-2025) & (K Units)
 Table 29. Global Epigenetic Kits Sales by Application (2026-2031) & (K Units)
 Table 30. Epigenetic Kits High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Epigenetic Kits Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Epigenetic Kits Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Epigenetic Kits ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Epigenetic Kits Growth Accelerators and Market Barriers
 Table 37. North America Epigenetic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Epigenetic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Epigenetic Kits Growth Accelerators and Market Barriers
 Table 40. Europe Epigenetic Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Epigenetic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Epigenetic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Epigenetic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Epigenetic Kits Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Epigenetic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Epigenetic Kits Investment Opportunities and Key Challenges
 Table 47. Central and South America Epigenetic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Epigenetic Kits Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Epigenetic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Illumina Corporation Information
 Table 51. Illumina Description and Major Businesses
 Table 52. Illumina Product Models, Descriptions and Specifications
 Table 53. Illumina Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Illumina Sales Value Proportion by Product in 2024
 Table 55. Illumina Sales Value Proportion by Application in 2024
 Table 56. Illumina Sales Value Proportion by Geographic Area in 2024
 Table 57. Illumina Epigenetic Kits SWOT Analysis
 Table 58. Illumina Recent Developments
 Table 59. Thermo Fisher Scientific Corporation Information
 Table 60. Thermo Fisher Scientific Description and Major Businesses
 Table 61. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 62. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 64. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 65. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 66. Thermo Fisher Scientific Epigenetic Kits SWOT Analysis
 Table 67. Thermo Fisher Scientific Recent Developments
 Table 68. Agilent Technologies Corporation Information
 Table 69. Agilent Technologies Description and Major Businesses
 Table 70. Agilent Technologies Product Models, Descriptions and Specifications
 Table 71. Agilent Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Agilent Technologies Sales Value Proportion by Product in 2024
 Table 73. Agilent Technologies Sales Value Proportion by Application in 2024
 Table 74. Agilent Technologies Sales Value Proportion by Geographic Area in 2024
 Table 75. Agilent Technologies Epigenetic Kits SWOT Analysis
 Table 76. Agilent Technologies Recent Developments
 Table 77. Merck KGaA Corporation Information
 Table 78. Merck KGaA Description and Major Businesses
 Table 79. Merck KGaA Product Models, Descriptions and Specifications
 Table 80. Merck KGaA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Merck KGaA Sales Value Proportion by Product in 2024
 Table 82. Merck KGaA Sales Value Proportion by Application in 2024
 Table 83. Merck KGaA Sales Value Proportion by Geographic Area in 2024
 Table 84. Merck KGaA Epigenetic Kits SWOT Analysis
 Table 85. Merck KGaA Recent Developments
 Table 86. Qiagen Corporation Information
 Table 87. Qiagen Description and Major Businesses
 Table 88. Qiagen Product Models, Descriptions and Specifications
 Table 89. Qiagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Qiagen Sales Value Proportion by Product in 2024
 Table 91. Qiagen Sales Value Proportion by Application in 2024
 Table 92. Qiagen Sales Value Proportion by Geographic Area in 2024
 Table 93. Qiagen Epigenetic Kits SWOT Analysis
 Table 94. Qiagen Recent Developments
 Table 95. Diagenode Corporation Information
 Table 96. Diagenode Description and Major Businesses
 Table 97. Diagenode Product Models, Descriptions and Specifications
 Table 98. Diagenode Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Diagenode Recent Developments
 Table 100. Active Motif Corporation Information
 Table 101. Active Motif Description and Major Businesses
 Table 102. Active Motif Product Models, Descriptions and Specifications
 Table 103. Active Motif Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Active Motif Recent Developments
 Table 105. Cayman Chemical Corporation Information
 Table 106. Cayman Chemical Description and Major Businesses
 Table 107. Cayman Chemical Product Models, Descriptions and Specifications
 Table 108. Cayman Chemical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Cayman Chemical Recent Developments
 Table 110. Aviva Biosciences Corporation Information
 Table 111. Aviva Biosciences Description and Major Businesses
 Table 112. Aviva Biosciences Product Models, Descriptions and Specifications
 Table 113. Aviva Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Aviva Biosciences Recent Developments
 Table 115. Zymo Research Corporation Information
 Table 116. Zymo Research Description and Major Businesses
 Table 117. Zymo Research Product Models, Descriptions and Specifications
 Table 118. Zymo Research Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Zymo Research Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Epigenetic Kits Product Picture
 Figure 2. Global Epigenetic Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Nucleic Acid Methylation Assay Kit Product Picture
 Figure 4. Chromatin Modification Detection Kit Product Picture
 Figure 5. Histone Methylation Assay Kit Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Epigenetic Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Oncology
 Figure 9. Developmental Biology
 Figure 10. Drug Discovery
 Figure 11. Others
 Figure 12. Epigenetic Kits Report Years Considered
 Figure 13. Global Epigenetic Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Epigenetic Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Epigenetic Kits Revenue Market Share by Region (2020-2031)
 Figure 17. Global Epigenetic Kits Sales (2020-2031) & (K Units)
 Figure 18. Global Epigenetic Kits Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Epigenetic Kits Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Epigenetic Kits Sales Volume Market Share in 2024
 Figure 21. Global Epigenetic Kits Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Nucleic Acid Methylation Assay Kit Revenue Market Share by Manufacturer in 2024
 Figure 24. Chromatin Modification Detection Kit Revenue Market Share by Manufacturer in 2024
 Figure 25. Histone Methylation Assay Kit Revenue Market Share by Manufacturer in 2024
 Figure 26. Other Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Epigenetic Kits Sales Market Share by Type (2020-2031)
 Figure 28. Global Epigenetic Kits Revenue Market Share by Type (2020-2031)
 Figure 29. Global Epigenetic Kits Sales Market Share by Application (2020-2031)
 Figure 30. Global Epigenetic Kits Revenue Market Share by Application (2020-2031)
 Figure 31. North America Epigenetic Kits Sales YoY (2020-2031) & (K Units)
 Figure 32. North America Epigenetic Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Epigenetic Kits Sales Revenue (US$ Million) in 2024
 Figure 34. North America Epigenetic Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 35. North America Epigenetic Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Epigenetic Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 37. North America Epigenetic Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Epigenetic Kits Sales YoY (2020-2031) & (K Units)
 Figure 42. Europe Epigenetic Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Epigenetic Kits Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Epigenetic Kits Sales Volume (K Units) by Type (2020-2031)
 Figure 45. Europe Epigenetic Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Epigenetic Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 47. Europe Epigenetic Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 49. France Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Epigenetic Kits Sales YoY (2020-2031) & (K Units)
 Figure 54. Asia-Pacific Epigenetic Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Epigenetic Kits Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Epigenetic Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Epigenetic Kits Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Epigenetic Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Epigenetic Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 64. India Epigenetic Kits Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Epigenetic Kits Sales YoY (2020-2031) & (K Units)
 Figure 66. Central and South America Epigenetic Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Epigenetic Kits Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Epigenetic Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 69. Central and South America Epigenetic Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Epigenetic Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 71. Central and South America Epigenetic Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Epigenetic Kits Sales YoY (2020-2031) & (K Units)
 Figure 75. Middle East and Africa Epigenetic Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Epigenetic Kits Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Epigenetic Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 78. South America Epigenetic Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Epigenetic Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Epigenetic Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Epigenetic Kits Revenue (2020-2025) & (US$ Million)
 Figure 85. Epigenetic Kits Industry Chain Mapping
 Figure 86. Regional Epigenetic Kits Manufacturing Base Distribution (%)
 Figure 87. Global Epigenetic Kits Production Market Share by Region (2020-2031)
 Figure 88. Epigenetic Kits Production Process
 Figure 89. Regional Epigenetic Kits Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Epigenetic Therapeutics Market Research Report 2024
Global Epigenetics Instrument Market Research Report 2025
Global DNA Methylation Detection Kit Market Research Report 2024
Global Epigenetics Services Market Research Report 2024
Global Epigenome Sequencing Market Research Report 2024
Global ChIP Kit Market Research Report 2024
Global GMO Test Kits Market Research Report 2024
Global NGS Kits Market Research Report 2025
Global DNA Test Kit Market Research Report 2024
Global Proteomic Kits Market Research Report 2024
Global Gene Editing Kit Market Research Report 2024
Epigenetics Drugs Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epigenome Analysis Services Market Research Report 2024
Global DNA Reagent Kits Market Research Report 2025
Global Kits for Scientific Research Market Research Report 2024
Global miRNA Kits Market Research Report 2024
Global DNA Extraction Kits Market Research Report 2024
Global Molecular Biology Kits Market Research Report 2025
Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025
Global Cell Free DNA Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions